Medications in pregnancy

Current Opinion in Obstetrics and Gynecology

Volumn 8, Issue 6, 1996, Pages 398-402

  Colie, Christine F ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; ANTICONVULSIVE AGENT; ANTIEMETIC AGENT; ANTIHYPERTENSIVE AGENT; ATENOLOL; BENDECTIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; FOLIC ACID; HYDRALAZINE; ISRADIPINE; LABETALOL; METHYLDOPA; METOCLOPRAMIDE; NIFEDIPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; PROMETHAZINE; PROPRANOLOL; PROPYLTHIOURACIL; PYRIDOXINE; THEOPHYLLINE; THIAMAZOLE; THYROID HORMONE; THYROXINE; TRIMETHADIONE; TRIMETHOBENZAMIDE; UNINDEXED DRUG; VALPROIC ACID;

ANTICONVULSANT THERAPY; ASTHMA; CLEFT LIP FACE PALATE; CLINICAL TRIAL; EPILEPSY; FOLIC ACID DEFICIENCY; HUMAN; HYPERTENSION; HYPERTHYROIDISM; HYPOTHYROIDISM; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NAUSEA; NEURAL TUBE DEFECT; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TERATOGENICITY;

EID: 0030447163     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-199612000-00003     Document Type: Review

References (49)

1. Bower C, Stanley FJ: Dietary folate as a risk factor for neural tube defects: evidence from a case-control study in Western Australia. Med J Aust 1989, 150:613-619.
2. Czeizel AE, Dudas I: Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 1992, 327:1832-1835.
3. Medical Research Council Vitamin Study Research Group: Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991, 338:131-139.
4. Wald NJ, Bower C: Folic acid and the prevention of neural tube defects. BMJ 1995, 310:1019-1020.
5. Metz J: Folate, B12 and neural tube defects. Med J Aust 1995, 163:231-232.
6. Rose NC, Mennuti MT: Periconceptional folic acid supplementation as a social intervention. Sem Perinat 1995, 19:243-254. A review article that encompasses most of the relevant issues of folic acid supplementation.
7. Czeizel AE: Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ 1993, 306:1645-1648.
8. Shaw GM, Lammer EJ, Wasserman CR, O'Malley CD, Tolarova MM: Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet 1995, 346:393-396. The authors showed a benefit of 0.4mg/day of folic acid against cleft lip and palate.
9. Vutyavanich T, Wongtra-Ngan S, Ruangsri R: Pyridoxine for nausea and vomiting of pregnancy: a randomized, double blind, placebocontrolled trial. Am J Obstet Gynecol 1995, 173:881-884.
10. Niebyl J, Maxwell KD: Treatment of the nausea and vomiting of pregnancy. In Drug Use in Pregnancy, edn 2. Edited by Niebyl J. Philadelphia: Lea and Febiger; 1988:11-19.
11. Milkovich L, van den Berg BJ: An evaluation of the teratogenicity of certain antinauseant drugs. Am J Obstet Gynecol 1976, 125:244-248.
12. Bylsma-Howell M, Riggs KW, McMorland GH, Rurak DW, Ongley R, McErlane B, Price JD, Axelson JE: Placental transfer of metoclopromide: assessment of maternal and neonatal effects. Can Anaesth Soc J 1983, 30:487-492.
13. Buehler BA, Delimont D, Van Waaes M, Finnell RH: Prenatal prediction of risk of the fetal hydantoin syndrome. N Engl J Med 1990, 322:22-26.
14. Thorp JA, Gaston L, Caspers DR, Pal ML: Current concepts and controversies in the use of vitamin K. Drugs 1995, 49:376-387. A review article on vitamin K pharmacology. Uses in medicine, neonatology, and obstetrics are evaluated and data on the use of vitamin K in preventing intracranial hemorrhage are presented.
15. Howe AM, Lipson AH, Sheffield LJ, Haan EA, Halliday JL, Jenson F, David DJ, Webster WS: Prenatal exposure to phenytoin, facial development, and a possible role for vitamin K. Am J Med Gen 1995, 58:238-244.
16. Reynolds EH: Anticonvulsants, folic acid and epilepsy. Lancet 1973, 1:1376-1388.
17. Shapiro S, Hartz SC, Siskind V, Mitchell AA, Slone D, Rosenberg L, Manson RR, Heinonen OP: Anticonvulsants and parental epilepsy in the development of birth defects. Lancet 1976, 1:272-276.
18. Jones KL, Lacro RV, Johnson BA: Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 1989, 320:1661-1666.
19. Ornoy A, Cohen I: Follow up studies of children born to epileptic women treated with carbamazepine. Teratology 1995, 51:169-173.
20. Kallen AFB: Maternal carbamazepine and Infant spina bifida. Reprod Toxicol 1994, 8:203-205.
21. Clericuzio CL: Fetal primidone effects. Proc Greenwood Genet Ctr 1985, 4:93-96.
22. Lindhout D, Hoppener RJ, Meinhard A: Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation of carbamazipine. Epilepsia 1984, 25:77-82.
23. Feldman GL, Weaver DD, Lovrien EW: The fetal trimethadione syndrome. Am J Dis Child 1977, 131:1389-1394.
24. Leung AS, Millar ULK, Koonings PP, Montoro M, Mestman JH: Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol 1993, 81:349-353.
25. Mestman JH: Diagnosis and management of hyperthyroidism in pregnancy. Curr Probl Obstet Gynecol 1981, 4:1-9.
26. Milharn S, Elledge W: Maternal methimazole use and congenital defects in children. Teratology 1972, 5:125-129.
27. Zuspan FP: Chronic hypertension in pregnancy. Clin Obstet Gynecol 1984, 27:854-861.
28. Fiddler GI: Propranolol and pregnancy. Lancet 1974, 2:722-726.
29. Butters L, Kennedy S, Rubin PC: Atenolol in essential hypertension in pregnancy. Br J Med 1990, 301:587-589.
30. Rasanen J, Jouppila P: Uterine and fetal hemodynamic and fetal cardiac function after atenolol and pindolol infusion: a randomized study. Eur J Obstet Gynecol Reprod Biol 1995, 62:195-201. This study used a randomized design to report hemodynamics changes by way of comparing agents. In so doing it gives evidence to effects from two important drugs.
31. Plouin PF, Breart G, Maillard F, Papiernik E, Reller JP: Comparison of antihypertensive efficacy and prenatal safety of labetolol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial. Br J Obstet Gynaecol 1988, 95:868-876.
32. Michael CA: The evaluation of labetolol in the treatment of hypertension complicating pregnancy. Br J Clin Pharmacol 1982, 13:127-131.
33. Sibai MB, Anderson GD: Pregnancy outcome of intensive therapy in severe hypertension in the first trimester. Obstet Gynecol 1986, 67:517-522.
34. Heinonen OP, Slone D, Shapiro S (Eds): Birth Defects and Drugs in Pregnancy. Littleton, Massachussets: Publishing Sciences Group, Massachussets; 1977:372.
35. Vink GF, Moodley J, Philpott RH: Effect of dihydralazine on the fetus in the treatment of maternal hypertension. Obstet Gynecol 1980, 55:519-522.
36. Briggs GG, Freeman RK, Yaffe SJ (Eds): Nifedipine summary. In Drugs in Pregnancy and Lactation, edn 4. Baltimore, Maryland: Williams and Wilkins 1994:621-624.
37. Constantine G, Beevers DG, Reynolds AL, Luesley DM: Nifedipine as a second line antihypertensive drug in pregnancy. Br J Obstet Gynaecol 1987, 94:1136-1142.
38. Lindow SW, Davies N, Davey DA, Smith JA: The effect of sublingual nifedipine on uteroplacental blood flow in hypertensive pregnancy. Br J Obstet Gynaecol 1988, 95:1276-1281.
39. Katimke G, van Kijk J, Dekker A, Van Geijn H: Ritodine and nifedipine as tocolytic agents: a preliminary comparison. J Perinat Med 1995, 23:409-415.
40. Wide-Swensson DH, Ingemarsson I, Lunell NO, Forman A, Skajaa K, Lindberg B, Lindberg S, Marsal K, Andersson K-E: Calcium channel blockade (isradipine) in treatment of hypertension in pregnancy: a randomized placebo controlled study. Am J Obstet Gynecol 1995, 173:872-878.
41. Fitzsimons R, Greenberger PA, Patterson R: Outcome of pregnancy in women requiring corticosteroids for severe asthma. J Allergy Clin Immunol 1986, 78:349-353.
42. Greenberger PA: Asthma in pregnancy. Clin Perinatol 1985, 12:571-584.
43. Carter BL, Driscoll CE, Smith GD: Theophylline clearance during pregnancy. Obstet Gynecol 1986, 68:555-559.
44. Hadjgeorgiov E, Kitsiov S, Psaroudakis A: Antepartum aminophylline treatment for prevention of the respiratory distress syndrome in premature infants. Am J Obstet Gynecol 1979, 135:257-261.
45. Schatz M, Zeiger RS, Harden KM: The safety of inhaled beta agonist bronchodilator during pregnancy. J Allergy Clin Immunol 1988, 82:686-695.
46. Briggs GG, Freeman RK, Yaffe SJ (Eds): Terbutaline summary. In Drugs in Pregnancy and Lactation, edn 4. Baltimore; Maryland: Williams and Wilkins 1994:803-806.
47. Greenberger PA, Patterson R: The management of asthma during pregnancy and lactation. Clin Rev Allergy 1987, 5:317-324.
48. Wilson J: Use of sodium cromoglycate during pregnancy. J Pharm Med 1982, 8:45-51.
49. Perlow JH, Montgomery D, Morgan MA: Severity of asthma and perinatal outcome. Am J Obstet Gynecol 1992, 167:963-967.